Statement Of Comprehensive Income [Abstract]

GenSight Biologics S.A. - Filing #2813015

Concept 2022-01-01 to
2022-12-31
2022-01-01 to
2022-12-31
2022-01-01 to
2022-12-31
2021-01-01 to
2021-12-31
2021-01-01 to
2021-12-31
2021-01-01 to
2021-12-31
Statement of comprehensive income [abstract]
Profit (loss)
27,625,000 EUR
27,625,000 EUR
28,617,000 EUR
28,617,000 EUR
Other comprehensive income [abstract]
Components of other comprehensive income that will not be reclassified to profit or loss, net of tax [abstract]
Other comprehensive income, net of tax, gains (losses) on remeasurements of defined benefit plans
50,000 EUR
50,000 EUR
8,000 EUR
8,000 EUR
Components of other comprehensive income that will be reclassified to profit or loss, net of tax [abstract]
Exchange differences on translation [abstract]
Other comprehensive income, net of tax, exchange differences on translation of foreign operations
174,000 EUR
174,000 EUR
215,000 EUR
215,000 EUR
Comprehensive income
27,625,000 EUR
124,000 EUR
27,748,000 EUR
28,617,000 EUR
207,000 EUR
28,824,000 EUR

Talk to a Data Expert

Have a question? We'll get back to you promptly.